Imatinib and beyond--the new CML study IV. A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemia.

Ann Hematol

III Medizinische Universitätsklinik, Klinikum Mannheim, Universität Heidelberg, Wiesbadener Strasse 7-11, 68305 Mannheim, Germany.

Published: April 2004

Download full-text PDF	Source
http://dx.doi.org/10.1007/s00277-003-0807-x	DOI Listing

Publication Analysis

imatinib beyond--the

beyond--the cml

cml study

study randomized

randomized controlled

controlled comparison

comparison imatinib

imatinib imatinib/interferon-alpha

imatinib/interferon-alpha imatinib/low-dose

imatinib/low-dose arac

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!